Management of recurrent viral hepatitis B and C after liver transplantation
โ Scribed by Marzia Montalbano; Guy W. Neff
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 157 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1522-8037
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: The value of immunohistochemical methods to identify hepatitis C virus antigen (HCVAg) in liver tissue has not been established. We have evaluated the significance of HCVAg expression in livers of patients with transplants and recurrent hepatitis C virus (HCV) infection. Methods: Fo
Hepatitis B (HBV) and C viral (HCV) dual-infectionassociated liver disease is an uncommon indication for liver transplantation. The clinical and virologic outcomes in such patients have not been well studied. We retrospectively studied 13 patients with hepatitis B surface antigen (HBsAg) and antibod
Several genotypes of hepatitis C virus (HCV) have been recently identified by phylogenetic analysis, but their clinical relevance in the liver transplant setting is unknown. We evaluated the incidence and course of recurrent hepatitis C after transplantation in 50 patients who underwent transplantat